Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Harvard Business School
AstraZeneca
Baxter
Express Scripts

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Oltipraz

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Oltipraz?

Oltipraz is an investigational drug.

There have been 5 clinical trials for Oltipraz. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2019.

The most common disease conditions in clinical trials are Fatty Liver, Non-alcoholic Fatty Liver Disease, and Liver Diseases. The leading clinical trial sponsors are PharmaKing, CJ HealthCare Corporation, and Northwestern University.

There are three hundred and forty-nine US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Oltipraz
TitleSponsorPhase
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseasePharmaKingPhase 2

See all Oltipraz clinical trials

Clinical Trial Summary for Oltipraz

Top disease conditions for Oltipraz
Top clinical trial sponsors for Oltipraz

See all Oltipraz clinical trials

US Patents for Oltipraz

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oltipraz   Start Trial Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA)   Start Trial
Oltipraz   Start Trial Pyrazolopyrimidine compounds GLAXOSMITHKLINE LLC (Wilmington, DE)   Start Trial
Oltipraz   Start Trial Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof vTv Therapeutics LLC (High Point, NC)   Start Trial
Oltipraz   Start Trial Methods for the prevention and the treatment of rapidly progressive glomerulonephritis INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS DESCARTES (Paris, FR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Oltipraz

Drugname Country Document Number Estimated Expiration Related US Patent
Oltipraz Austria 448323 2023-03-05   Start Trial
Oltipraz Australia 2004218354 2023-03-05   Start Trial
Oltipraz Australia 2006216545 2023-03-05   Start Trial
Oltipraz Australia 2009245838 2023-03-05   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Baxter
Boehringer Ingelheim
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.